Veravas Revenue and Competitors
Estimated Revenue & Valuation
- Veravas's estimated annual revenue is currently $2.6M per year.
- Veravas's estimated revenue per employee is $155,000
Employee Data
- Veravas has 17 Employees.
- Veravas grew their employee count by -19% last year.
Veravas's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder and CEO | Reveal Email/Phone |
2 | CFO | Reveal Email/Phone |
3 | Chief Scientific Officer | Reveal Email/Phone |
4 | Principal Scientist | Reveal Email/Phone |
5 | Senior Scientific Advisor | Reveal Email/Phone |
6 | Process Scientist | Reveal Email/Phone |
7 | Process Scientist | Reveal Email/Phone |
8 | Board Advisor | Reveal Email/Phone |
Veravas Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7.8M | 50 | 9% | N/A | N/A |
#2 | $7.4M | 48 | -35% | N/A | N/A |
#3 | $0.9M | 6 | 20% | N/A | N/A |
#4 | $0.3M | 2 | -91% | N/A | N/A |
#5 | $3.6M | 23 | 5% | N/A | N/A |
#6 | $0.9M | 6 | -33% | N/A | N/A |
#7 | $5M | 32 | 3% | N/A | N/A |
#8 | $14.7M | 95 | 9% | N/A | N/A |
#9 | $14.7M | 95 | 0% | $20.5M | N/A |
#10 | $27.9M | 144 | 13% | $39.1M | N/A |
What Is Veravas?
Veravas, Inc. is an early-stage biotechnology company focused on transforming the practice of laboratory medicine with technology that delivers superior test results, providing confidence to clinicians and patients that diagnostic tests when performed are accurate. The company is rapidly driving the commercialization of proprietary sample preparation and sample interference products and development of new diagnostic tests for the IVD marketplace. Veravas is currently developing IVD testing solutions for the COVID-19 market utilizing its proprietary nanobead technology and VeraPrepâ„¢ reagents. To learn more about our technologies and clinical applications, visit veravas.com
keywords:N/A
N/A
Total Funding
17
Number of Employees
$2.6M
Revenue (est)
-19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Veravas News
Veravas's nanomagnetic particles will recognize, eliminate and measure substances from sample of patients to reduce the effects of complex...
... such as Scantibodies or Veravas, can be used to remove heterophile antibodies or biotin from the patient sample.
Other Companies in Oakdale
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.7M | 21 | -22% | N/A |
#2 | $4M | 21 | -5% | N/A |
#3 | $2.3M | 22 | -4% | N/A |
#4 | $2.7M | 24 | -11% | N/A |
#5 | $2.4M | 24 | -17% | N/A |